Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Modified Dahuang Huanglian Xiexin Mouthwash is a Chinese herbal formulation developed by Union Hospital, Tongji Medical College, Huazhong University of Science and Technology. It is derived from the classic Traditional Chinese Medicine (TCM) formula Dahuang Huanglian Xiexin Decoction, specifically modified to enhance its therapeutic properties for the prevention and treatment of radiotherapy-induced oral mucositis (RTOM). The active ingredients include extracts from *Rhei Radix et Rhizoma* (Dahuang), *Coptidis Rhizoma* (Huanglian), and *Scutellariae Radix* (Huangqin). These botanical components are rich in bioactive compounds such as berberine, baicalin, and emodin, which provide potent anti-inflammatory, antioxidant, and antimicrobial effects. The mouthwash is intended to mitigate mucosal damage caused by ionizing radiation by inhibiting pro-inflammatory cytokines and oxidative stress pathways in the oral cavity.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on modified dahuang huanglian xiexin mouthwash.